Drug Chatter -- Tracking biopharma stock chatter

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

UserTweets
@livetraderalrt 10
@j_jccnidan 8
@WeekHerald 6
@dailypoliticaln 5
@filingBot 5

Recent Tweets for XLRN

AmericanBanking @AmericanBanking
Christopher Rovaldi Sells 11,000 Shares of Acceleron Pharma Inc $XLRN Stock https://t.co/exQWvz93Me #stocks
January 17th 2018, 7:01pm
InsiderAlertsIA @InsiderAlertsIA
$XLRN: New Insider Filing on SVP, Program Mgmt and Ops CHRISTOPHER ROVALDI: https://t.co/1FPjlZre6X
January 17th 2018, 5:01pm
filingBot @filingBot
@altafmubaraki there is a new form 4 filing for $XLRN https://t.co/ZGdz17eK9S Fav if you like.
January 17th 2018, 5:01pm
windham_kathryn @windham_kathryn
Ghost Tree Capital Holding in Acceleron Pharma $XLRN Increased as Shares Declined https://t.co/iM3ijqhSRJ
January 17th 2018, 9:01am
livetraderalrt @livetraderalrt
$XLRN 3.2m ago: Consolidated Research: 2018 Summary Expectations for Eclipse Resources, Unit, Post, Acceleron Pharm… https://t.co/5HrgZnhCzu
January 17th 2018, 8:01am
MariaDa18810214 @MariaDa18810214
Ghost Tree Capital Increased By $9.62 Million Its Acceleron Pharma $XLRN Holding https://t.co/ZrUQStC9xE
January 16th 2018, 4:01pm
windham_kathryn @windham_kathryn
Acceleron Pharma Inc. $XLRN Reaches $45.83 52-Week High https://t.co/Ul1o8fQuz4
January 16th 2018, 2:01pm
Margare30926081 @Margare30926081
Ghost Tree Capital Boosted Its Stake in Acceleron Pharma $XLRN by $9.62 Million https://t.co/5RoIDhHE8K
January 16th 2018, 8:01am
MariaDa18810214 @MariaDa18810214
Perceptive Advisors Upped Its Position in Acceleron Pharma $XLRN by $33.49 Million https://t.co/u9F2vQ4JL6
January 15th 2018, 3:01pm
noritsunagirota @noritsunagirota
Perceptive Advisors Has Lifted Acceleron Pharma $XLRN Stake By $33.49 Million https://t.co/XHiiKPWdZx
January 14th 2018, 2:01pm
noritsunagirota @noritsunagirota
Acceleron Pharma Inc. $XLRN Reaches $45.12 52-Week High https://t.co/gysRvI0iLF
January 14th 2018, 11:01am
OlympiaReport @OlympiaReport
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Acceleron Pharma $XLRN Share Price https://t.co/8u6Vr9rNLx
January 14th 2018, 4:01am
TheMarketsDaily @TheMarketsDaily
Acceleron Pharma $XLRN Hits New 52-Week High at $44.98 https://t.co/HHRmR19NiH
January 14th 2018, 2:01am
noritsunagirota @noritsunagirota
Acceleron Pharma $XLRN Share Value Declined While Birchview Capital LP Lifted by $370,000 Its Position ...
January 13th 2018, 4:01pm
j_jccnidan @j_jccnidan
$XLRN BO confirmed based on the volume BUY BUY BUY
January 12th 2018, 3:01pm
j_jccnidan @j_jccnidan
$XLRN Buy as we go to $50
January 12th 2018, 2:01pm
j_jccnidan @j_jccnidan
$XLRN Moving on volume
January 12th 2018, 1:01pm
dailypoliticaln @dailypoliticaln
Acceleron Pharma $XLRN Stock Rating Reaffirmed by Oppenheimer https://t.co/fuuZuvQbYh
January 12th 2018, 1:01pm
Biotech2050 @Biotech2050
Dear $CELG @Celgene You will regret not having bought out $XLRN EOM
January 12th 2018, 1:01pm
LargeVoidBot @LargeVoidBot
13:03 New 52wk Highs: $XLRN
January 12th 2018, 1:01pm
WatchlistN @WatchlistN
Acceleron Pharma $XLRN Given Hold Rating at Cann https://t.co/F8ER9q5BBo
January 12th 2018, 12:01pm
BioWino @BioWino
$xlrn stalking that 52 week high of 44.8
January 12th 2018, 12:01pm
dispatchtribune @dispatchtribune
Acceleron Pharma’s $XLRN “Hold” Rating Reiterated at Oppenheimer https://t.co/Ql1Ma7xDfV
January 11th 2018, 10:01am
WeekHerald @WeekHerald
Acceleron Pharma $XLRN Earns “Hold” Rating from Cann https://t.co/LqbIOy1Opx
January 11th 2018, 10:01am
dailypoliticaln @dailypoliticaln
Acceleron Pharma $XLRN Rating Reiterated by Cann https://t.co/fXPvczYXFC
January 11th 2018, 10:01am
ConsumerFeed @ConsumerFeed
Oppenheimer Reiterates “Hold” Rating for Acceleron Pharma $XLRN https://t.co/koe2NqmNIG
January 11th 2018, 10:01am
SADIFAnalytics @SADIFAnalytics
Is Acceleron Pharma Inc Ready to Takeoff? $XLRN https://www.sadifanalytic
January 11th 2018, 10:01am
WeekHerald @WeekHerald
Ameriprise Financial Inc. Buys Shares of 33,430 Acceleron Pharma Inc $XLRN https://t.co/9ECLgnnbw6
January 11th 2018, 7:01am
TickerReport @TickerReport
Ameriprise Financial Inc. Acquires Shares of 33,430 Acceleron Pharma Inc $XLRN https://t.co/HOR4dWgIbx
January 11th 2018, 4:01am
j_jccnidan @j_jccnidan
$XLRN Bullish move today as it pulled back at the open then retested the resistance level that we will break thru tomorrow
January 10th 2018, 9:01pm
j_jccnidan @j_jccnidan
$XLRN 5 day ascending triangle....Buy for the breakout https://t.co/8DRNS4yKfO
January 10th 2018, 3:01pm
brockthornhill @brockthornhill
RT @JasonHolman5: $XLRN definitely has a healthy mix of large catalysts (2-PH3 readouts)&initiations(4) across a diverse pipeline. The dat…
January 10th 2018, 8:01am
dispatchtribune @dispatchtribune
Acceleron Pharma $XLRN Rating Reiterated by Cann https://t.co/qMbdwyluQA
January 10th 2018, 8:01am
MarieSm76375904 @MarieSm76375904
Qvt Financial LP Has Decreased Its Holding in Acceleron Pharma $XLRN as Stock Price Declined ...
January 10th 2018, 7:01am
noritsunagirota @noritsunagirota
Acceleron Pharma $XLRN Position Has Raised by Perceptive Advisors Llc https://t.co/iQ0bAy2nVs
January 10th 2018, 5:01am
JasonHolman5 @JasonHolman5
$XLRN definitely has a healthy mix of large catalysts (2-PH3 readouts)&initiations(4) across a diverse pipeline. T… https://t.co/WfcTrcS1JE
January 9th 2018, 11:01pm
JasonHolman5 @JasonHolman5
Encouraging to see some positive valuation out of $XLRN after they passed the first real test of their neuromuscula… https://t.co/uesdgHjb9S
January 9th 2018, 8:01pm
TranscriptDaily @TranscriptDaily
Oppenheimer Reiterates “Hold” Rating for Acceleron Pharma $XLRN https://t.co/0i2eqoRxUU
January 9th 2018, 4:01pm
bbnsnews @bbnsnews
Acceleron Pharma $XLRN Receives “Hold” Rating from Oppenheimer https://t.co/drF5hDL2IK
January 9th 2018, 4:01pm
joaquinkam @joaquinkam
RT @Biotech2050: $XLRN at #JPM18 Link to presentation https://t.co/IVi7suByxb Link to slides https://t.co/ebgkfN9zij
January 9th 2018, 3:01pm
j_jccnidan @j_jccnidan
$XLRN Jerry show me the money......
January 9th 2018, 2:01pm
j_jccnidan @j_jccnidan
$XLRN Getting ready to retest the n DT level that will result in a break out
January 9th 2018, 9:01am
bbnsnews @bbnsnews
Acceleron Pharma $XLRN Receiving Somewhat Favorable Press Coverage, Analysis Shows https://t.co/3dFOYMxU2c
January 9th 2018, 7:01am
MarieSm76375904 @MarieSm76375904
Ravindra Kumar, an Insider in Acceleron Pharma Inc. $XLRN, Unloaded 4300 shares of the Company ...
January 9th 2018, 6:01am
wosaikeneriki @wosaikeneriki
As Acceleron Pharma $XLRN Stock Value Declined, Shareholder Ghost Tree Capital Lifted Its Position ...
January 9th 2018, 5:01am
Biotech2050 @Biotech2050
$XLRN at #JPM18 Link to presentation https://t.co/IVi7suByxb Link to slides https://t.co/ebgkfN9zij
January 9th 2018, 3:01am
CMTNeuropathy @CMTNeuropathy
RT @AcceleronPharma: At #JPM18, our CEO Habib Dable highlights $XLRN’s long-term vision & commitment in our 3 focused therapeutic areas: he…
January 8th 2018, 6:01pm
AcceleronPharma @AcceleronPharma
At #JPM18, our CEO Habib Dable highlights $XLRN’s long-term vision & commitment in our 3 focused therapeutic areas:… https://t.co/G2Vq4erjt7
January 8th 2018, 5:01pm
AmericanBanking @AmericanBanking
Acceleron Pharma $XLRN Stock Rating Reaffirmed by Cann https://t.co/jxQRGvl5HX #stocks
January 8th 2018, 5:01pm
ZolmaxNews @ZolmaxNews
Acceleron Pharma $XLRN Earns “Hold” Rating from Cann https://t.co/Otst9YqkaW
January 8th 2018, 4:01pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.